Vaccine News and Research

Latest Vaccine News and Research

Testing for mRNA-1283, Moderna's next generation COVID-19 vaccine commences

As vaccine efforts against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease, roll out in various countries, Moderna ups the game by testing its next-generation COVID-19 vaccine.

16 Mar 2021

Janssen’s vaccine added to list of safe, effective tools against COVID-19

The World Health Organization (WHO) today listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use in all countries and for COVAX roll-out. The decision comes on the back of the European Medicines Agency (EMA) authorization, which was announced yesterday.

16 Mar 2021

New strategy may change the course of evolving COVID-19 pandemic

Launched in April 2020 by the World Health Organization (WHO), European Commission, France and The Bill & Melinda Gates Foundation, the ACT Accelerator is a partnership of leading public health agencies with equity at its heart.

16 Mar 2021

Study explores how SARS-CoV-2 mutations produce antibody resistance and enhanced transmissibility

An interesting new study deals with the effects of the natural mutations in the spike antigen of the SARS-CoV-2, the pathogen that is responsible for the ongoing coronavirus disease pandemic.

16 Mar 2021

New study tests how mutations in SARS-CoV-2 affect antibody neutralization

Using pseudoviruses with single amino acid substitutions, researchers found that mutations in SARS-CoV-2 reduce monoclonal antibody neutralization differently. However, convalescent sera samples did not lose neutralization potency many and were also effective against the B.1.1.7 (UK-derived) strain.

16 Mar 2021

Use of artificial intelligence to tackle coronavirus must go through ethical checks, say experts

Rapid deployment of artificial intelligence and machine learning to tackle coronavirus must still go through ethical checks and balances, or we risk harming already disadvantaged communities in the rush to defeat the disease.

16 Mar 2021

Chimeric vaccines may provide universal protection against viruses like SARS-CoV-2

Researchers in the United States have developed “chimeric” vaccines that provided cross-protection against different strains of sarbecovirus in mice, including the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19).

15 Mar 2021

New Phase 1 study evaluates prime/boost HIV-1 vaccine formulated with combinations of adjuvants

A new Phase 1 vaccine study began today that will evaluate experimental prime/boost HIV-1 vaccine regimens formulated with combinations of different adjuvants, including one from the Army Liposome Formulation (ALF) family of adjuvants developed by scientists with the U.S. Military HIV Research Program at the Walter Reed Army Institute of Research.

15 Mar 2021

The role of nanotechnology in the fight against COVID-19

Appearing in the journal Nanomedicine, the review summarized all the exciting advances made using diverse nanomaterials (polymeric, inorganic self-assembling materials and peptide-based) towards COVID-19 prevention, diagnosis and therapy.

15 Mar 2021

What is a protective neutralizing antibody titer against SARS-CoV-2 infection?

A new study describes a predictive model of protective immunity against SARS-CoV-2 infection that could help evolve optimal vaccination strategies to maintain protection and reduce the death rate.

15 Mar 2021

Which biomarkers can help predict severe COVID-19?

The ability to detect potentially fatal illness early on in the course of the disease would enable a swift prioritization of these high-risk individuals for treatment. A new preprint on the medRxiv* server presents an array of biomarkers that may help achieve this laudable goal.

15 Mar 2021

Neutralizing nanobodies effective against SARS-CoV-2 variants

Nanobodies have different mechanisms to neutralize viruses, and some target epitopes not accessible to monoclonal antibodies, making them an alternative for developing therapies for COVID-19.

15 Mar 2021

The boom in out-of-state telehealth threatens in-state providers

When the Hazelden Betty Ford Foundation began offering telehealth services in Montana in early February, the nation's largest nonprofit addiction treatment provider promised quality care for far-flung residents without their even having to leave home.

15 Mar 2021

Covid cases plummet 83% among nursing home staffers despite vaccine hesitancy

Joan Phillips, a certified nursing assistant in a Florida nursing home, loved her job but dreaded the danger of going to work in the pandemic. When vaccines became available in December, she jumped at the chance to get one.

15 Mar 2021

Study suggests COVID-19 vaccine acceptance on the rise in UK

A team of researchers in the UK recently conducted a two-wave survey on the hesitancy of individuals to receive COVID-19 vaccination.

15 Mar 2021

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

In a recent bioRxiv preprint research paper, Botond Z. Igyártó and colleagues from Thomas Jefferson University demonstrated the inflammatory nature of the lipid nanoparticles (LNPs).

15 Mar 2021

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

A recent study, currently available on the bioRxiv preprint server, indicates that a pair of dual-action monoclonal antibodies derived from an original 2003 SARS survivors could play an important role in the fight against coronavirus disease 2019 (COVID-19) due to their broadly neutralizing activity and the engagement of the immune system via effector function capabilities.

14 Mar 2021

Vaccine News and Research

Latest Vaccine News and Research

Testing for mRNA-1283, Moderna's next generation COVID-19 vaccine commences

Janssen’s vaccine added to list of safe, effective tools against COVID-19

New strategy may change the course of evolving COVID-19 pandemic

Study explores how SARS-CoV-2 mutations produce antibody resistance and enhanced transmissibility

New study tests how mutations in SARS-CoV-2 affect antibody neutralization

Use of artificial intelligence to tackle coronavirus must go through ethical checks, say experts

Chimeric vaccines may provide universal protection against viruses like SARS-CoV-2

New Phase 1 study evaluates prime/boost HIV-1 vaccine formulated with combinations of adjuvants

The role of nanotechnology in the fight against COVID-19

What is a protective neutralizing antibody titer against SARS-CoV-2 infection?

Which biomarkers can help predict severe COVID-19?

Neutralizing nanobodies effective against SARS-CoV-2 variants

The boom in out-of-state telehealth threatens in-state providers

Covid cases plummet 83% among nursing home staffers despite vaccine hesitancy

Study suggests COVID-19 vaccine acceptance on the rise in UK

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

CUNY SPH receives prestigious Harrison C. Spencer Award for Outstanding Community Service

New vaccination method aims at comprehensive protection against all known influenza mutations

Neutralizing antibodies induced by COVID-19 vaccines less effective against new variants

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in